Abstract
Simple isolation of (±)‐schizandrin (1) and preparation of its analogues (6–8) via acylation of (±)‐schizandrin (1) are described. The key strategy in the synthesis involves the catalytic acylation reaction of 1 with several acylating reagents.
Acknowledgments
This project was supported by a grant/cooperative agreement from the Centers for Disease Control and Prevention (CDC). The U.S. Department of Agriculture, Agricultural Research Service Specifc Cooperative Agreement No. 58‐6408‐2‐0009 and Food and Drug Administration, FD‐U‐002071‐01 are acknowledged for partial support of this work.